Truong Vu 4
4 · Aridis Pharmaceuticals, Inc. · Filed Dec 7, 2022
Insider Transaction Report
Form 4
Truong Vu
DirectorCEO, CSO, Director10% Owner
Transactions
- Award
Restricted Stock Units
2022-12-05+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]15,000 shares of Common Stock will vest on June 5, 2023 and 15,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.